Healthlead PCL (HL.BK) Stock Price

Healthlead PCL Price

CLOSED
5.60THB-0.05 (-0.89 %)
Market closed

Over the last 8 years Healthlead PCL grew revenue by 15.6% annually, reaching 2.23 B THB. Earnings per share have grown at 8.8% per year over the last 5 years. For Healthlead PCL, the net margin of 3.5% is down versus 6.6% a few years ago. At today's price the dividend yield works out to roughly 3.04%. The payout ratio is around 58% of earnings. The dividend has grown at 2.0% per year over the past 3 years. The consensus 12-month price target for Healthlead PCL is 12.24 THB, about 118.6% above where the stock trades today. Of 8 analysts, 0 rate the stock a buy — an overall Sell consensus. The stock trades about 2% above its 52-week low.

Healthlead PCL stock price

Volume
Ex-Dividend
Details

Stock Price

ⓘ

How to Read This Chart

This chart tracks the historical stock price of Healthlead PCL over time. You can switch between daily, weekly, and monthly views and select custom time ranges — from a single day to the full available history. Use the toggle to view price changes in absolute currency terms or as a percentage change relative to the starting date.

Total Return vs. Price Return

The "Total Return" toggle includes reinvested dividends on top of the pure price movement. This is critical because dividends can account for a significant portion of long-term returns. Historically, roughly 40 % of the S&P 500's total return has come from dividends. Always compare total return when evaluating a stock's real performance against a benchmark.

Intraday Price Data

When viewing a one-day time frame, the chart displays real-time intraday price movements. This is useful for observing how Healthlead PCL stock reacts to market openings, earnings releases, or breaking news throughout the trading session.

What to Look For

Look for long-term trends (sustained upward or downward movements over months and years), support and resistance levels (price zones where the stock repeatedly bounces or reverses), and volatility (how much the price fluctuates day to day). Comparing Healthlead PCL's price chart to a market index like the S&P 500 can reveal whether the stock is outperforming or underperforming the broader market.

Healthlead PCL Stock Price History
DateHealthlead PCL Price
8/5/20265.60 THB
8/4/20265.65 THB
8/3/20265.60 THB
7/31/20265.65 THB
7/30/20265.65 THB
7/29/20265.65 THB
7/28/20265.65 THB
7/27/20265.65 THB
7/24/20265.80 THB
7/23/20265.75 THB
7/22/20265.85 THB
7/21/20265.85 THB
7/20/20265.80 THB
7/17/20265.80 THB
7/16/20265.80 THB
7/15/20265.80 THB
7/14/20265.80 THB
7/13/20265.80 THB
7/10/20265.75 THB
7/9/20265.75 THB
7/8/20265.65 THB
7/7/20265.55 THB
7/6/20265.60 THB
7/3/20265.60 THB
7/2/20265.55 THB
7/1/20265.55 THB
6/30/20265.60 THB
6/29/20265.60 THB
6/26/20265.50 THB
6/25/20265.60 THB
6/24/20265.55 THB
6/23/20265.60 THB
6/22/20265.55 THB
6/19/20265.55 THB
6/18/20265.55 THB
6/17/20265.50 THB
6/16/20265.60 THB
6/15/20265.60 THB
6/12/20265.65 THB
6/11/20265.70 THB
6/10/20265.55 THB
6/9/20265.65 THB
6/8/20265.70 THB
6/5/20265.70 THB
6/4/20265.75 THB
6/3/20265.85 THB
6/2/20265.85 THB
6/1/20265.80 THB
5/29/20265.80 THB
5/28/20265.85 THB
5/27/20265.95 THB
5/26/20265.90 THB
5/25/20265.95 THB
5/22/20265.90 THB
5/21/20265.90 THB
5/20/20265.95 THB
5/19/20265.95 THB
5/18/20266.05 THB
5/15/20266.20 THB
5/14/20266.10 THB
5/13/20266.05 THB
5/12/20266.00 THB
5/11/20265.85 THB
5/8/20265.85 THB
5/7/20265.85 THB
5/6/20266.15 THB
5/5/20266.25 THB
5/4/20266.25 THB
5/1/20266.25 THB
4/30/20266.25 THB
4/29/20266.25 THB
4/28/20266.25 THB
4/27/20266.40 THB
4/24/20266.25 THB
4/23/20266.20 THB
4/22/20266.30 THB
4/21/20266.30 THB
4/20/20266.40 THB
4/17/20266.40 THB
4/16/20266.45 THB
4/10/20266.25 THB
4/9/20266.15 THB
4/8/20266.25 THB
4/7/20266.20 THB
4/3/20266.10 THB
4/2/20266.10 THB
4/1/20266.25 THB
3/31/20266.15 THB
3/30/20266.20 THB
3/27/20266.20 THB
3/26/20266.10 THB
3/25/20266.25 THB
3/24/20266.40 THB
3/23/20266.40 THB
3/20/20266.50 THB
3/19/20266.65 THB
3/18/20266.85 THB
3/17/20266.65 THB
3/16/20266.65 THB
3/13/20266.60 THB
3/12/20266.65 THB
3/11/20266.75 THB
3/10/20266.90 THB
3/9/20266.85 THB
3/6/20267.05 THB
3/5/20267.05 THB
2/26/20267.10 THB
2/25/20267.10 THB
2/24/20267.10 THB
2/23/20267.20 THB
2/20/20267.30 THB
2/19/20267.30 THB
2/18/20267.20 THB
2/17/20267.20 THB
2/16/20267.20 THB
2/13/20267.20 THB
2/12/20267.25 THB
2/11/20267.20 THB
2/10/20267.20 THB
2/9/20267.15 THB
2/6/20267.15 THB
2/5/20267.20 THB
2/4/20267.10 THB
2/3/20267.15 THB
2/2/20267.00 THB
1/30/20267.00 THB
1/29/20267.00 THB
1/28/20267.00 THB
1/27/20267.05 THB
1/26/20267.00 THB
1/23/20267.10 THB
1/22/20267.10 THB
1/21/20267.10 THB
1/20/20267.15 THB
1/19/20267.10 THB
1/16/20267.10 THB
1/15/20267.10 THB
1/14/20267.00 THB
1/13/20266.95 THB
1/12/20267.00 THB
1/9/20267.05 THB
1/8/20267.10 THB
1/7/20267.10 THB
1/6/20267.10 THB
1/5/20267.20 THB
12/30/20257.20 THB
12/29/20257.05 THB
12/26/20257.10 THB
12/25/20257.00 THB
12/24/20257.05 THB
12/23/20257.05 THB
12/22/20257.00 THB
12/19/20257.00 THB
12/18/20256.95 THB
12/17/20257.00 THB
12/16/20257.00 THB
12/15/20256.60 THB
12/12/20256.30 THB
12/11/20256.20 THB
12/9/20256.40 THB
12/8/20256.30 THB
12/4/20256.30 THB
12/3/20256.60 THB
12/2/20256.70 THB
12/1/20256.80 THB
11/28/20256.90 THB
11/27/20256.75 THB
11/26/20256.80 THB
11/25/20256.50 THB
11/24/20256.50 THB
11/21/20256.80 THB
11/20/20256.95 THB
11/19/20257.05 THB
11/18/20257.40 THB
11/17/20257.15 THB
11/14/20257.10 THB
11/13/20257.10 THB
11/12/20257.25 THB
11/11/20257.65 THB
11/10/20257.65 THB
11/7/20257.60 THB
11/6/20257.55 THB
11/5/20257.60 THB
11/4/20257.65 THB
11/3/20257.65 THB
10/31/20257.50 THB
10/30/20257.70 THB
10/29/20257.50 THB
10/28/20257.60 THB
10/27/20257.60 THB
10/24/20257.45 THB
10/22/20257.50 THB
10/21/20257.45 THB
10/20/20257.60 THB
10/17/20257.60 THB
10/16/20257.70 THB
10/15/20257.60 THB
10/14/20257.60 THB
10/10/20257.80 THB
10/9/20257.80 THB
10/8/20258.05 THB
10/7/20258.05 THB
10/6/20258.05 THB
10/3/20258.10 THB
10/2/20258.10 THB
10/1/20258.10 THB
9/30/20257.60 THB
9/29/20257.70 THB
9/26/20257.60 THB
9/25/20257.60 THB
9/24/20257.65 THB
9/23/20257.80 THB
9/22/20257.75 THB
9/19/20257.80 THB
9/18/20257.75 THB
9/17/20257.70 THB
9/16/20257.80 THB
9/15/20257.80 THB
9/12/20257.80 THB
9/11/20257.75 THB
9/10/20257.65 THB
9/9/20257.65 THB
9/8/20257.30 THB
9/5/20257.30 THB
9/4/20257.30 THB
9/3/20257.30 THB
9/2/20257.35 THB
9/1/20257.25 THB
8/29/20257.25 THB
8/28/20257.30 THB
8/27/20257.20 THB
8/26/20257.25 THB
8/25/20257.30 THB
8/22/20257.30 THB
8/21/20257.25 THB
8/20/20257.30 THB
8/19/20257.25 THB
8/18/20257.30 THB
8/15/20257.30 THB
8/14/20257.20 THB
8/13/20257.30 THB
8/8/20257.30 THB
8/7/20257.25 THB
Access this data via the Eulerpool API
Get Free API Key

Healthlead PCL Revenue, EBIT, Net Income

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue
EBIT
Net Income
Details
Date
Revenue
EBIT
Net Income
Jan 1, 2019
906.22 M THB
32.52 M THB
21.77 M THB
Jan 1, 2020
1.06 B THB
73.52 M THB
52.08 M THB
Jan 1, 2021
1.20 B THB
102.64 M THB
79.66 M THB
Jan 1, 2022
1.52 B THB
148.39 M THB
118.23 M THB
Jan 1, 2023
1.64 B THB
103.02 M THB
74.68 M THB
Jan 1, 2024
1.98 B THB
107.43 M THB
78.26 M THB
Jan 1, 2025
2.23 B THB
73.48 M THB
77.86 M THB
Jan 1, 2026 (e)
2.37 B THB
156.33 M THB
111.52 M THB

Healthlead PCL Income Statement, Balance Sheet, Cash Flow Statement

Last updated Aug 7, 2026, 4:41 AM
 
REVENUEB THB
REVENUE GROWTH%
GROSS MARGIN%
GROSS INCOMEM THB
EBITM THB
EBIT MARGIN%
NET INCOMEM THB
NET INCOME GROWTH%
DIV.THB
DIV. GROWTH%
SHARESM
2017201820192020202120222023202420252026e
0.700.780.911.061.201.521.641.982.232.37
–11.4116.0117.4412.5926.797.6420.9212.706.42
16.5517.5420.0921.8023.0424.7523.0623.4722.4922.49
116.00137.00182.00232.00276.00376.00377.00464.00501.00533.16
-5.00-1.0032.0073.00102.00148.00103.00107.0073.00156.00
-0.71-0.133.536.868.519.746.305.413.286.58
-9.00–21.0052.0079.00118.0074.0078.0077.00111.00
–––147.6251.9249.37-37.295.41-1.2844.16
–––––0.160.180.150.170.17
––––––12.50-16.6713.33–
266.22266.22266.22272.00272.00272.00272.00272.00266.22266.22
Details

Income Statement Key Figures

ⓘ

Revenue and Revenue Growth

Revenue is the starting point of every income statement — it measures the total sales Healthlead PCL generates from its core business. Revenue growth (expressed as year-over-year percentage change) is one of the most important indicators of business momentum. Sustained growth above 10 % annually is generally considered strong, while declining revenue is a serious warning sign that demands investigation.

Gross Margin

Gross margin = (Revenue − Cost of Goods Sold) ÷ Revenue. It reveals what percentage of each dollar of revenue Healthlead PCL retains after direct production costs. High gross margins (above 50 %) are typical of asset-light businesses like software and brands, while capital-intensive industries like manufacturing often operate below 30 %. Compare Healthlead PCL's gross margin to industry peers and track it over time to spot improving or deteriorating pricing power.

EBIT and EBIT Margin

EBIT measures operating profit — what remains after subtracting all operating expenses (including R&D, sales, and administrative costs) from gross profit. The EBIT margin shows this as a percentage of revenue. Because it excludes interest and taxes, EBIT allows fair comparisons between companies with different debt levels and tax jurisdictions. A rising EBIT margin indicates improving operational efficiency.

Net Income and Earnings Per Share (EPS)

Net income is the company's final profit after all expenses, interest, and taxes. Dividing net income by the number of shares outstanding gives you EPS — the single most influential metric in stock valuation. Consistent EPS growth is the primary driver of long-term stock price appreciation. Always check whether EPS growth comes from genuine profit improvement or from share buybacks reducing the share count.

Shares Outstanding

The total number of shares Healthlead PCL has issued. A declining share count (through buybacks) boosts EPS and signals management confidence. A rising share count (through stock issuance) dilutes existing shareholders. Always monitor this number alongside EPS to get the full picture of per-share value creation.

Analyst Estimates

The projected figures represent consensus estimates from professional analysts. Compare these forecasts against Healthlead PCL's historical growth rates to assess whether expectations are realistic. A company that consistently beats consensus estimates tends to see its stock price rewarded over time, while repeated misses erode investor confidence.

Healthlead PCL stock margins

The Healthlead PCL margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Healthlead PCL. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Healthlead PCL.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Gross margin
EBIT margin
Profit margin
Details
Date
Gross margin
EBIT margin
Profit margin
Jan 1, 2019
20.09 %
3.59 %
2.40 %
Jan 1, 2020
21.89 %
6.91 %
4.89 %
Jan 1, 2021
23.05 %
8.56 %
6.65 %
Jan 1, 2022
24.76 %
9.77 %
7.78 %
Jan 1, 2023
23.06 %
6.30 %
4.57 %
Jan 1, 2024
23.51 %
5.43 %
3.96 %
Jan 1, 2025
22.50 %
3.30 %
3.49 %
Jan 1, 2026 (e)
22.50 %
6.59 %
4.70 %

Healthlead PCL Stock Revenue, EBIT, Earnings per Share

The Healthlead PCL earnings per share therefore indicates how much revenue Healthlead PCL has generated per share in a given period. The earnings before interest and taxes per share shows how much of the operating profit corresponds to each share. The earnings per share indicates how much of the profit belongs to each share.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Revenue per Share
EBIT per share
Earnings per Share
Details
Date
Revenue per Share
EBIT per share
Earnings per Share
Jan 1, 2019
0.00 THB
0.00 THB
0.00 THB
Jan 1, 2020
3.91 THB
0.27 THB
0.19 THB
Jan 1, 2021
4.41 THB
0.38 THB
0.29 THB
Jan 1, 2022
5.59 THB
0.55 THB
0.43 THB
Jan 1, 2023
6.01 THB
0.38 THB
0.27 THB
Jan 1, 2024
7.27 THB
0.39 THB
0.29 THB
Jan 1, 2025
8.37 THB
0.28 THB
0.29 THB
Jan 1, 2026 (e)
8.72 THB
0.59 THB
0.41 THB

Healthlead PCL business model & stock analysis

Healthlead PCL Eulerpool Fair Value

Details

Fair Value Estimate

ⓘ

What Is Fair Value?

Fair value is an estimate of what a stock is truly "worth" based on its financial fundamentals, independent of the current market price. If the calculated fair value is above the current share price, the stock may be undervalued — and vice versa. This chart shows three different fair value approaches so you can cross-check them against each other.

Earnings-Based Fair Value

Calculated by multiplying the current earnings per share (EPS) by the average historical P/E ratio over a selected multi-year period. The smoothing over several years filters out temporary spikes or dips. If this fair value exceeds the market price, it suggests the stock is cheap relative to its earning power.

Example: Fair Value (Earnings) 2022 = EPS 2022 × Average P/E 2019–2021

Revenue-Based Fair Value

Derived by multiplying revenue per share by the average historical price-to-sales ratio. This method is particularly useful for companies with volatile or temporarily depressed earnings, as revenue tends to be more stable than profits. It answers: "At what price has the market historically valued each dollar of this company's sales?"

Example: Fair Value (Revenue) 2022 = Revenue per Share 2022 × Average P/S 2019–2021

Dividend-Based Fair Value

Calculated by dividing the dividend per share by the average historical dividend yield. This approach is most relevant for mature, consistently dividend-paying companies. If the resulting fair value is higher than the current price, it implies the stock offers a better yield than its historical average.

Example: Fair Value (Dividend) 2022 = Dividend per Share 2022 ÷ Average Yield 2019–2021

How to Use This Chart

When all three fair value lines converge above the current price, it strengthens the case that the stock is undervalued. When they diverge, investigate why — it may indicate a structural shift in margins, payout policy, or growth rate. The forward estimates on the right extend the analysis using projected fundamentals, helping you assess whether the current price already reflects future growth expectations.

Healthlead PCL historical P/E ratio, EBIT multiple, and P/S ratio

Healthlead PCL annual returns

Details

Annual Return

ⓘ

What This Chart Shows

This chart breaks down 's total annual return into two components: price return (gains or losses from stock price movement) and dividend return (income received from dividend payments). Together, they represent the total return an investor would have earned in each calendar year.

Price Return

Price return measures the percentage change in 's stock price from January 1st to December 31st of each year. Positive bars indicate the stock appreciated; negative bars show a decline. This is the component most investors focus on, but it tells only part of the story — especially for dividend-paying stocks.

Dividend Return

Dividend return represents the income generated from dividends paid during the year, expressed as a percentage of the starting stock price. While it may seem small in any single year (typically 1–4 % for established companies), dividends compound significantly over decades and have historically contributed roughly 40 % of total stock market returns.

What to Look For

Examine how many years showed positive vs. negative returns to gauge consistency. A stock with mostly positive years and small drawdowns suggests lower risk. Also compare 's annual returns to a benchmark index — consistently outperforming the market is a hallmark of a strong investment. Pay attention to the worst years: understanding downside risk is just as important as chasing upside potential.

Healthlead PCL shares outstanding

The number of shares of Healthlead PCL was 266.22 M in 2025. This indicates how many shares Healthlead PCL is divided into. Since shareholders are the owners of a company, each share represents a small portion of the company's ownership.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Number of stocks
Details
Date
Number of stocks
Jan 1, 2019
272.00 M Stocks
Jan 1, 2020
272.00 M Stocks
Jan 1, 2021
272.00 M Stocks
Jan 1, 2022
272.00 M Stocks
Jan 1, 2023
272.00 M Stocks
Jan 1, 2024
272.00 M Stocks
Jan 1, 2025
266.22 M Stocks
Jan 1, 2026 (e)
266.22 M Stocks

Healthlead PCL Dividend History

4 years of dividend payments

YearAnnual DividendYoY ChangePayments
20250.17THB↑ 13.3%1×
Mar 14, 20250.17THB↑ 13.3%1/1
20240.15THB↓ 16.7%1×
20230.18THB↑ 12.5%1×
20220.16THB—1×

Healthlead PCL dividend history and estimates

In 2025, Healthlead PCL paid a dividend amounting to 0.17 THB. Dividend means that Healthlead PCL distributes a portion of its profits to its owners.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Dividend
Dividend (Estimate)
Details
Date
Dividend
Dividend (Estimate)
Jan 1, 2022
0.16 THB
0.00 THB
Jan 1, 2023
0.18 THB
0.00 THB
Jan 1, 2024
0.15 THB
0.00 THB
Jan 1, 2025
0.17 THB
0.00 THB
Jan 1, 2026 (e)
0.00 THB
0.17 THB

Healthlead PCL dividend payout ratio

In 2025, Healthlead PCL had a payout ratio of 58.13%. The payout ratio indicates the percentage of the company's profits that Healthlead PCL distributes as dividends.

  • 3 Years

  • 5 Years

  • 10 Years

  • 25 Years

  • Max

Payout ratio
Details
Date
Payout ratio
Jan 1, 2019
58.61 %
Jan 1, 2020
58.61 %
Jan 1, 2021
58.61 %
Jan 1, 2022
36.81 %
Jan 1, 2023
65.56 %
Jan 1, 2024
52.13 %
Jan 1, 2025
58.13 %
Jan 1, 2026 (e)
42.31 %

Current Healthlead PCL forecasts and price targets in August 2026

Analyst Price Targets 2026
Δ MOM Price Target
0.00 %
Buy
0.00 % (0)
Hold
37.50 % (3)
Sell
62.50 % (5)
12M Price Target
12.24
Last Price
5.60
Currency
THB
12M Return Potential
118.57 %
LTM Return
0 %

Healthlead PCL shareholder structure

% Name
24.31471%
Bhandhukanonda (Supakorn)
Bhandhukanonda (Supakorn)
18.54809%
Tantanasin (Araya)
Tantanasin (Araya)
10.43199%
Bhandhukanonda (Mataya)
Bhandhukanonda (Mataya)
8.42897%
Manosuthi (Sumet)
Manosuthi (Sumet)
4.33824%
Chonwattanasakul (Thatchapon)
Chonwattanasakul (Thatchapon)
2.74368%
Bhandhukanonda (Thanyakorn)
Bhandhukanonda (Thanyakorn)

Healthlead PCL Beneficial Ownership Filings (SEC 13D/G)

Free Float
19.4%
Float Shares
-
Shares Outstanding
-

Healthlead PCL Executives and Management Board

13 members · avg. age 48 · 62 % women

Management

PC

Pol. Capt. Thatchaphon Chonwattanasakul (44)

Chief Executive Officer, Acting Chief Business Development Officer, Acting IT Director, Executive Director · since 2018

–
AT

Mrs. Araya Tantanasin (51)

Chief Financial Officer, Company Secretary

–
SB

Mr. Supakorn Bhandhukanonda (34)

Chief Operating Officer, Executive Director · since 2018

–

Board of Directors

AH

Asst. Prof. Apirudee Hemajuta (65)

Non-Executive Independent Chairman of the Board

100,000.00 THB
TK

Mr. Thanasak Kulrattanarak (48)

Non-Executive Independent Director

100,000.00 THB
MT

Mrs. Marayart Teeratomorn (52)

Non-Executive Independent Director

100,000.00 THB
TP

Ms. Tatim Prakitnonthakarn (50)

Finance Director

–
JK

Ms. Jariya Kwanjareon (43)

Accounting Director

–
MB

Ms. Mataya Bhandhukanonda (63)

Executive Director · since 2018

–

Frequently asked questions about Healthlead PCL

Analysts currently set an average price target of 12.24 THB for the Healthlead PCL stock (median: 12.24 THB), implying +118.6 % versus the latest price. The consensus is based on 8 analyst ratings.

Healthlead PCL Analyst Price Targets 2026

8 analysts currently rate the Healthlead PCL stock: 0 recommend buying, 3 holding and 5 selling. For 2026, analysts expect Healthlead PCL to generate revenue of 2.37 B THB and earnings per share of 0.42 THB.

Healthlead PCL Analyst Price Targets 2026

Converted at the current exchange rate, the Healthlead PCL share trades at 0.15 EUR (5.60 THB).

No history available for Healthlead PCL.

The expected revenue of Healthlead PCL is 2.37 B THB. This figure is based on current financial data and reflects the company's business performance.

The expected profit of Healthlead PCL is 111.52 M THB. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of Healthlead PCL is currently 13.37. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the Healthlead PCL stock.

The price-to-sales ratio (P/S) of Healthlead PCL is currently 0.63. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the Healthlead PCL stock.

The Eulerpool Quality Score for Healthlead PCL is 2/10.

The ISIN of Healthlead PCL is THA598010009. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of Healthlead PCL is HL.BK. The ticker symbol is used to trade Healthlead PCL shares on the stock exchange.

Over the past 12 months, Healthlead PCL paid a dividend of 0.17 THB . This corresponds to a dividend yield of about 3.04 %. For the coming 12 months, Healthlead PCL is expected to pay a dividend of 0.17 THB.

The current dividend yield of Healthlead PCL is 3.04 %.

Healthlead PCL pays a dividend, distributed in the months of , , , .

Healthlead PCL paid dividends every year for the past 4 years.

For the upcoming 12 months, dividends amounting to 0.17 THB are expected. This corresponds to a dividend yield of 3.01 %.

Healthlead PCL is assigned to the 'Non-cyclical consumption' sector.

To receive the latest dividend of Healthlead PCL from amounting to 0.17 THB, you needed to have the stock in your portfolio before the ex-date on .

The last dividend was paid out on .

In the year 2025, Healthlead PCL distributed 0.15 THB as dividends.

The dividends of Healthlead PCL are distributed in THB.

All fundamentals and in-depth analysis of Healthlead PCL

Our stock analysis for Healthlead PCL stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Healthlead PCL. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.

Healthlead PCL Stock
Healthlead PCL Revenue→
Healthlead PCL Stock
Healthlead PCL Net Income→
Healthlead PCL Stock
Healthlead PCL P/E→
Healthlead PCL Stock
Healthlead PCL P/S→
Healthlead PCL Stock
Healthlead PCL EBIT→
Healthlead PCL Stock
Healthlead PCL Dividend→
Healthlead PCL Stock
Healthlead PCL Directors Dealings→
Healthlead PCL Stock
Healthlead PCL Stocks→
Healthlead PCL Stock
Healthlead PCL Market capitalization→
Healthlead PCL Stock
Healthlead PCL Debt→
Healthlead PCL Stock
Healthlead PCL Liabilities→
Healthlead PCL Stock
Healthlead PCL Equity→
Healthlead PCL Stock
Healthlead PCL AAQS→
Healthlead PCL Stock
Healthlead PCL Employees→
Healthlead PCL Stock
Healthlead PCL ROE→
Healthlead PCL Stock
Healthlead PCL ROA→
Healthlead PCL Stock
Healthlead PCL ROCE→
Healthlead PCL Stock
Healthlead PCL News→
Healthlead PCL Stock
Healthlead PCL Analyst Price Targets→

Non-cyclical consumption Stocks

Healthy BrainHealthier Choices ManagementHealthy Coffee InternationalHealth Sciences GroupHealthy Life AgritecHealth and Happiness (H&H) International HoldingsHebei Hengshui Laobaigan Liquor CoHB GlobalHebei Yangyuan ZhiHui Beverage CoHayashikane Sangyo CoHeilongjiang Agriculture CoHawesko HoldingAll Stocks A–Z →